Recent News

• 11.13.2025 - Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update
• 10.07.2025 - Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025
• 08.06.2025 - Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update
• 08.06.2025 - Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update
• 08.06.2025 - Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update
• 06.25.2025 - Arbutus Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical Focus
• 06.25.2025 - Arbutus Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical Focus

Recent Filings

• 11.13.2025 - EX-99.1 EX-99.1
• 11.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.13.2025 - 8-K Current report
• 10.07.2025 - 8-K Current report
• 10.07.2025 - EX-99.1 EX-99.1
• 09.10.2025 - EX-99.1 EX-99.1
• 09.10.2025 - 8-K Current report
• 08.13.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.06.2025 - 8-K Current report
• 08.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]